# Vyvanse vs Mydayis warnings

## Summary
why does vyvanse have so many more warnings than mydayis Vyvanse *looks* like it has a lot more warnings than Mydayis, but the reason isn’t that it’s more dangerous. It’s mostly **regulatory formatting + how the FDA classifies each drug**, not the actual risk difference. Here’s the real explanation, in plain terms: --- # ✅ **1. Vyvanse is in a “different regulatory bucket”** Vyvanse (lisdexamfetamine) is approved for: - **ADHD (kids, teens, adult...

## Projects
- Vyvanse vs Mydayis warnings

## Next Actions
- [ ] People who need to be fully “on” by **7–8am sharp**.
- [ ] Still **not focusing like you need to**
- [ ] If you want, next step we can:

## Key Points
- why does vyvanse have so many more warnings than mydayis Vyvanse *looks* like it has a lot more warnings than Mydayis, but the reason isn’t that it’s more dangerous.
- It’s mostly **regulatory formatting + how the FDA classifies each drug**, not the actual risk difference.
- Here’s the real explanation, in plain terms: --- # ✅ **1.
- Vyvanse is in a “different regulatory bucket”** Vyvanse (lisdexamfetamine) is approved for: - **ADHD (kids, teens, adults)** - **Binge Eating Disorder (BED)** Because it treats *two* conditions—one psychiatric and one eating-disorder related—the FDA requires: 
- Vyvanse is a *prodrug*, so the FDA adds “mechanism-based warnings”** Vyvanse is inactive until your body converts it to dextroamphetamine.
- This leads the FDA to include: - Extra warnings about slow activation - Warnings about misuse methods (snorting doesn’t activate it) - Abuse liability language specific to prodrugs - Special pharmacokinetic notes Mydayis doesn’t need these—it's just mixed amph

## Open Questions
- - Is it dose, duration, tolerance, or possibly something like sleep or mood?
